Seven ways to reduce infections among people who inject drugs: Joint guidance reportArchived
’Prevention of infections among people who inject drugs is achievable and effective – if it is properly executed’, stresses ECDC Director Marc Sprenger. In recent years, many European countries have achieved substantial progress in preventing drug-related infections. Drug injecting, however, remains a major cause of infectious diseases across Europe. The interventions proposed in the guidance report range from the supply of injection equipment, testing and vaccination to the treatment of infections and drug dependence. These are best applied in combination and ideally in the same venue for maximum effect.
In their guidance report Prevention and control of infectious diseases among people who inject drugs, the agencies explore good and evidence-based public health practices that can support effective policies to reduce infections. Common blood-borne viruses in this group include HIV, hepatitis B and C as well as tuberculosis. Launching the report during a meeting of infectious disease experts in Lisbon today, the two agencies aim to support countries across Europe in their efforts to reduce infection risks.
It is always time to test: Spring European Testing Week
21 May 2019 - In order to maximise the benefits of treatment for HIV or viral hepatitis, it is critical to test and diagnose people as soon as possible in the course of the infection. ECDC supports this objective of European Testing Week.
Health risks during the Carnival season in Brazil
7 Feb 2019 - The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
Ending the HIV epidemic: where does Europe stand?
30 Nov 2018 - From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia. The main issues: diagnosing those who are unaware of their HIV infection and treating them.